Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Medico Intercontinental Ltd has filed newspaper clippings (in English and Gujarati) of its unaudited standalone and consolidated financial results for the quarter and nine months ended 31 December 2025, as required under SEBI LODR regulations. The Board approved these results at its meeting held on 14 February 2026. On a standalone basis, the company swung back to profit with a Q3 net profit of Rs 61.15 lakhs versus a loss of Rs 46.09 lakhs in the year-ago quarter, while nine-month net profit jumped to Rs 175.95 lakhs from Rs 60.37 lakhs. Total income from operations for the nine months rose to Rs 4,025.31 lakhs from Rs 3,830.34 lakhs. However, on a consolidated basis, the company remains in loss, though narrower, with a nine-month net loss of Rs 864.79 lakhs versus a similar loss last year.
The standalone turnaround and nearly 3x jump in nine-month net profit are positive signals for shareholders, suggesting improving core business performance. The persistent consolidated losses, however, indicate weakness in subsidiary operations and may weigh on investor sentiment.